Hematocrit and drug interference study of the new arkray glucocard S onyx blood glucose meter meeting ISO 15197:2013 accuracy criteria – a contribution to patient safety

Introduction Abnormal HCT levels and medications can cause inaccurate readings with blood glucose meters (BGM) in routine practice. The GLUCOCARD S onyx (ARKRAY Inc.) BGM was evaluated over a wide HCT range (20-70%) and its interaction with 27 common drug interferences, as per ISO15197:2013/EN ISO15197:2015, compared to clinical laboratory reference methods.